Antimicrobial resistance point-of-care test for gonorrhoea
In a study commissioned by the Review on Antimicrobial Resistance, Aquarius Population Health worked with modellers at the University of Bristol to create a mathematical model. The model was used to assess the economic implications and treatment impact of introducing a hypothetical antimicrobial resistance (AMR) point-of-care test (POCT) for gonorrhoea. Results of the study were Read More >
Antimicrobial resistance: Why it matters
Antimicrobial resistance (AMR) has been described as one of the world’s greatest threats to human and animal health. Some reports suggest that by 2050, AMR could kill around 10 million people each year worldwide. Public health leaders warn we could enter a ‘post-antibiotic’ era where easily treatable common infections become untreatable. Read More >
Antimicrobial Resistance: Innovation in rapid diagnostics
Part 3: What role does innovation such as rapid diagnostics have in preventing AMR? Just as new technology has helped us in the fight against global warming (fuel efficiency, clean energy etc.), technology can also help us in the fight against antimicrobial resistance (AMR). One such area is rapid diagnostics – identified as a key Read More >
Point of care testing: Disruptive innovation – is the NHS ready for it yet?
Our Managing Director, Elisabeth Adams, spoke in November about the importance of exploring the health economics of point of care testing (POCT) at the Royal Society of Medicine Telemedicine and eHealth event in London. Why is it important to explore the health economics of point of care testing (POCT)? Evaluating the health economics of POCTs Read More >
Understanding barriers to implementing point-of-care tests in paediatric patients
The team at Aquarius Population Health investigated the experience of implementing point-of-care tests (POCTs) for paediatric patients during respiratory disease season (winter 2014 – spring 2015), in collaboration with colleagues from three large hospitals in South London (Guy’s and St. Thomas’, King’s College Hospital, and St. George’s University Hospital). Each centre independently evaluated one POCT test (Enigma® MiniLab™ FluAB-RSV PCR assay, BioMérieux BioFire Filmarray, and Luminex RVP Fast v2) on paediatric patients either in the Accident and Emergency department or admitted as an inpatient. Read More >
Rapid on-demand testing of HPV and cervical cancer prevention: IPV Conference in Lisbon
Aquarius Population Health will be presenting European screening programmes outcomes and opportunities for rapid HPV testing in the UK at the 2015 HPV conference in Lisbon. http://www.hpv2015.org Read More >